Gelonghui September 26th | Yirui Biology (300942.SZ) recently stated during a specific stakeholder research that the company's current accounts receivable repayment situation is stable. Different types and regions of customers have varying repayment cycles for accounts receivable, with government customers being mainly affected by bidding requirements, local fiscal budgets, and other factors. The company also adopts flexible management by prepaying part of the accounts and using various payment modes based on specific customer situations.
易瑞生物(300942.SZ)：公司目前应收账款回款情况稳定
Yirui Biology (300942.SZ): The current situation of accounts receivable collection for the company is stable.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.